Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAVA Therapeutics N.V.

1.24
-0.0400-3.12%
Volume:12.62K
Turnover:15.65K
Market Cap:32.62M
PE:-1.32
High:1.27
Open:1.21
Low:1.21
Close:1.28
Loading ...

BRIEF-Lava Therapeutics Granted Full Waiver For RVO Payment Obligation

Reuters
·
16 Apr

LAVA Therapeutics Granted Full Waiver for Rvo Payment Obligation

THOMSON REUTERS
·
16 Apr

LAVA Therapeutics Nv: Exemption From $5.1 Mln Repayment Obligation

THOMSON REUTERS
·
16 Apr

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

GlobeNewswire
·
16 Apr

Investors Aren't Buying LAVA Therapeutics N.V.'s (NASDAQ:LVTX) Revenues

Simply Wall St.
·
06 Apr

Lava Therapeutics Price Target Maintained With a $1.50/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

LAVA Therapeutics Nv : Leerink Partners Cuts Target Price to $1 From $2

THOMSON REUTERS
·
31 Mar

JMP Securities Sticks to Its Hold Rating for LAVA Therapeutics (LVTX)

TIPRANKS
·
29 Mar

LAVA Therapeutics NV reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

BRIEF-LAVA Therapeutics Q4 Basic EPS USD -0.14

Reuters
·
28 Mar

Press Release: LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Dow Jones
·
28 Mar

LAVA Therapeutics NV expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

LAVA Therapeutics NV expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
14 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

BRIEF-LAVA Therapeutics NV Receives Nasdaq Non-Compliance Notice For Minimum Bid Price

Reuters
·
01 Mar

LAVA Therapeutics Nv - Receives Nasdaq Non-Compliance Notice for Minimum Bid Price

THOMSON REUTERS
·
01 Mar

Lava Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
27 Feb

LAVA Therapeutics Nv : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
27 Feb